Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3).
Sebastian DekkersDehan ComezNoemi KarsaiMarta Arimont-SeguraMeritxell CanalsBirgit CasparChris de GraafLaura E KilpatrickRob LeursBarrie KellamStephen J HillStephen J BriddonMichael J StocksPublished in: ACS medicinal chemistry letters (2023)
The atypical chemokine receptor 3 (ACKR3) is a receptor that induces cancer progression and metastasis in multiple cell types. Therefore, new chemical tools are required to study the role of ACKR3 in cancer and other diseases. In this study, fluorescent probes, based on a series of small molecule ACKR3 agonists, were synthesized. Three fluorescent probes, which showed specific binding to ACKR3 through a luminescence-based NanoBRET binding assay (p K d ranging from 6.8 to 7.8) are disclosed. Due to their high affinity at the ACKR3, we have shown their application in both competition binding experiments and confocal microscopy studies showing the cellular distribution of this receptor.